pharmacological interventionTIGIT inhibitorsEtigilimabNational Cancer InstitutecancerRilvegostomigTIGIT inhibitorPD1 inhibitorDargistotugacademic centres
…logy is uncertain, imposing significant risks to the search for pharmacological intervention. But, by joining a ‘herd’, that risk may be perceived to be dim…